

KOELIS the global leader in MRI/Ultrasound Prostate Fusion Biopsy has developed Trinity®, a fully integrated prostate fusion biopsy system specifically created for personalized care.
Equipped with KOELIS’ Exclusive highly validated Organ-Based Tracking Fusion® and multiparametric image fusion, Trinity® enables the physician to pinpoint with exact precision MRI lesions and record targeted & systematic prostate biopsy locations on a digitized 3D patient-specific prostate map.
Once associated to Steady-Pro® and MrDraw®, Trinity® becomes the ultimate solution for prostate cancer care.
Powered by the patented and clinically validated Organ-Based Tracking fusion® (OBT Fusion®) technology, targeted prostate biopsy can easily be performed under local or general anesthesia with a 2.3mm target accuracy. Elastic Fusion + OBT Fusion® = 2.3mm Accuracy
Trinity® is effectively integrated within the health system, fostering multidisciplinary communication for better prostate cancer detection, management and patient monitoring.
Freehand, user-friendly and with minimal instrumentation, Trinity® increases productivitywhile improving the patient’s experience in both hospital and office settings.
The Organ-Based Tracking Fusion® (OBT Fusion®) is a patented KOELIS innovation that works in tandem with elastic fusion technology. Unlike other technologies that track the movement of the probe, OBT Fusion® tracks the shifting prostate and automatically compensates for its movements therefore maximising the accuracy of the procedure. Trinity® prostate fusion biopsy system is the only one in the world equipped with this technology.
Easily integrated in routine clinical practice, TRINITY® supports both transrectal and transperineal sampling approaches even under local anesthesia.
Quality control is guaranteed in both biopsy methods thanks to a simple interface that improves precision while saving time.
You can get detailed information from the global product's webpage from here or you can contact us directly.